Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for YASMIN
- Aspirin for the Management of Endometriosis-associated Pelvic Pain
- The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics
- Binge Eating & Birth Control
- Efficacy of Dienogest Versus Oral Contraceptive Pills on Pain Associated With Endometriosis
- Continuous Versus Cyclical OCP Use in PCOS
- Treatment Choice in Primary Dysmenorrhea
- Study to Assess the Effect of Metformin Supplementation on IVF Outcome in Patients With Polycystic Ovarian Syndrome.
- The Effect of Oral Contraceptive Pills On Eyes
- Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure
- Miniflare Versus Long Protocol in Poor Responders
- Combined Oral Contraceptives and Fluoxetine Versus Combined Oral Contraceptives in Severe Premenstrual Syndrome
- Continuous Versus Cyclic Oral Contraceptives for Endometriosis
- Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
- Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants
- Comparison of Body Weight Change During Contraception With Belara and Yasmin
- Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome
- Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome
- hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF
- A Study to Evaluate the Effectiveness of NuvaRing® to Prevent Pregnancies in Chinese Women (P06450)
- Assessment of the Pharmacodynamic Effect on Plasma Folate and Red Blood Cell Folate and Comparison of the Folate Metabolites During the 24 Weeks of Treatment (Yasmin + Metafolin Versus Yasmin + Folic Acid) Followed by a 20 Week Elimination Phase of
- LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study
- Investigation of Bioequivalence of Ethinylestradiol (EE) and Drospirenone (DRSP) in Two Different Tablet Formulations: Yasmin and Yasmin + Levomefolate Calcium (Metafolin) & L-5-MTHF in Two Different Tablet Formulations: Levomefolate Calcium (Metafo
- A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
- Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being
- Yasmin Post Marketing Surveillance
- Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects
- Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)
- Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
- Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
- Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers
- Oral Contraceptive and Cardiovascular Risk in PCOS
- Metabolic Syndrome in PCOS: Precursors and Interventions
- Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722)
- Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life.
- A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
- Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives
Clinical trials list
click for details